<DOC>
	<DOCNO>NCT02031211</DOCNO>
	<brief_summary>Studying effect Etanercept ( anti-Tumor Necrosis Factor alpha ) early Chronic Regional Pain Syndrome ( CRPS ) . Our hypothesis Etanercept improve patient symptom give early CRPS .</brief_summary>
	<brief_title>TNF-alpha Inhibition CRPS : A Randomized Controlled Trial</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>1 . Female pediatric Chronic Regional Pain Syndrome ( CRPS ) patient unilateral CRPS low extremity , age 1017 year age . 2 . Patients must meet CRPS Type I diagnostic criterion current evidence edema , temperature difference affect contralateral limb ≥1.0°C . 3 . Duration symptom less 4 month . 1 . Active malignancy history malignancy . 2 . Active infection . 3 . History Tuberculosis ( TB ) TB exposure . 4 . Pregnancy . 5 . Concomitant disease cause immunocompromise . 6 . Concomitant autoimmune disease rheumatoid arthritis , psoriasis , ankylose spondylitis Crohn 's Disease . 7 . Poorly control psychiatric disease include anxiety , depression attention deficit hyperactivity disorder . 8 . Hepatic renal impairment indicate serum transaminase and/or creatinine ≥ 150 % normal value age . 9 . Evidence history demyelinate disease .</criteria>
	<gender>Female</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>